Skip to main content
Clinical Trials/JPRN-UMIN000004487
JPRN-UMIN000004487
Completed
Phase 2

Phase II Trial of Preoperative Chemotherapy and Bevacizumab in Patients With Stage IIIA Non-Squamous Non-Small Cell Lung Cancer - Phase II Trial of Preoperative Chemotherapy and Bevacizumab

Osaka International Cancer Institute0 sites30 target enrollmentNovember 1, 2010

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
on-squamous, Non-small cell lung cancer
Sponsor
Osaka International Cancer Institute
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 1, 2010
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Active double cancer 2\)Current history of hemoptysis 3\)Evidence of bleeding diathesis or coagulopathy 4\)With great vessel invasion 5\)Cavity in tumor 6\)History of uncontrollable pericardial effusion 7\)History of severe heart disease 8\)Current or previous history (within the last 1 year) of symptomatic cerebrovascular disease 9\)Active infectious disease in need of intravenous administration of anti\-bacterial, anti\-fungal, or anti\-viral drugs 10\)Receiving anticoagulant drug (except Aspirin within 324 mg/day) 11\)Uncontrollable Gastrointestinal ulceration 12\)Current or previous(within the last 1 year)history of GI perforation 13\)Uncontrollable systemic disease (hyper tension or diabetes mellitus) 14\)Interstitial pneumonia or pulmonary fibrosis detectable on chest Xp 15\)Peripheral neuropathy \> Grade2 16\)With a history of drug sensitivity 17\)History of pregnancy or lactation 18\)No intention to practice birth control 19\)Patients whose participation in the trial is judged to be inappropriate by the attending doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials